SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001453938-14-000004
Filing Date
2014-08-26
Accepted
2014-08-26 12:25:17
Documents
2

Document Format Files

Seq Description Document Type Size
1 sc13g.txt SC 13G/A 10522
2 sc13g.pdf SC 13G/A 185631
  Complete submission text file 0001453938-14-000004.txt   268041
Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500
Transcept Pharmaceuticals Inc (Subject) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-81821 | Film No.: 141064530
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8150 N. CENTRAL EXPRESSWAY SUITE 650 DALLAS TX 75206
Business Address 8150 N. CENTRAL EXPRESSWAY SUITE 650 DALLAS TX 75206 (972) 861-1059
Prosight Fund, LP (Filed by) CIK: 0001453938 (see all company filings)

IRS No.: 263706825 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A